Table 1.
Overall | CVD (n = 10) | AD/MCI (n = 8) | FTD (n = 5) | PD (n = 11) | ALS (n = 5) | |
---|---|---|---|---|---|---|
Age (years) | 68 (45–83) | 72 (55–76) | 73 (62–82) | 57 (48–83) | 65 (59–76) | 65 (45–73) |
Sex (n, % Female) | 14 (36%) | 3 (30%) | 2 (25%) | 2 (40%) | 5 (45%) | 2 (40%) |
Education (n, % with post-secondary education) | 35 (90%) | 9 (90%) | 8 (100%) | 5 (100%) | 10 (91%) | 3 (60%) |
MoCA (0–30)a [n = 32] | 25 (16–30) | 27 (16–30) | 24 (22–27)e | ‡¶ | 27 (17–28)d | 24 (22–25)d |
mRS (0–5)b [n = 33] | 2 (0–4) | 1 (0–3)d | 2 (0–3) | 3 (3–4)d | 2 (1–3)e | ‡ |
PSQI (0–21)b [n = 33] | 6 (0–14) | 5 (0–9)e | 4 (1–7)d | 11 (5–12)d | 5 (2–14)e | 8 (4–13) |
GAD-7 (0–21)b [n = 38] | 2 (0–16) | 1 (0–12) | 1 (0–4) | 2 (0–7)d | 4 (0–9) | 5 (0–16) |
QIDS-SR (0–26)bc [n = 37] | 5 (1–12) | 3 (2–10) | 3 (1–8)d | 4 (2–12)d | 8 (3–12) | 9 (6–12) |
MoCA Montreal Cognitive Assessment, mRS Modified Rankin Scale, PSQI Pittsburgh Sleep Quality Index, GAD-7 General Anxiety Disorder-7, QIDS-SR Quick Inventory of Depressive Symptomology-Self-Report
Data are presented as median (range) unless otherwise noted
aHigher score indicates greater functioning
bLower score indicates greater functioning
cTotal score for QIDS-SR adjusted to 26 (question 12 was not collected as a part of the ReMiNDD study)
Missing data for: done participant; eTwo participants
‡For subgroups of less than four participants (3 or fewer scores), cohort level summaries are not reported
¶Missing MoCA scores were attributed to participants who were unable to complete the assessment due to cognitive impairment